Blog

Blog Category:

Breast Cancer

2/19/2009
David M. Paul
Comments (0)

Bone Density Drug Tibolone Found to Increase Risk of Breast Cancer Recurrence

The February 2009 issue of The Lancet Oncology reports that a breast cancer patient´s risk of recurrence increases considerably with the use of Tibolone, a synthetic steroid used in preventing osteoporosis and treating menopausal symptoms.  As a result, breast cancer survivors and current breast cancer patients should not be givenTibolone.

In August, 2008, The New England Journal of Medicine reported that Tibolone increases the risk of stroke in older women.


Bookmark and Share


There are no comments.

Post a comment

Post a Comment to "Bone Density Drug Tibolone Found to Increase Risk of Breast Cancer Recurrence"

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Username:*

Password:*

Register for an account

Message:

Notify me of follow-up comments via email.

For security purposes, please enter the graphic text in the box below: [hit F5 if you can not read the text]